Asia Pacific Neurostimulation Devices Market, By Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others), By Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others), By Country, Competition, Forecast & Opportunities, 2028

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Asia Pacific neurostimulation devices market is expected to grow at a significant rate during the forecast period. The factors driving the growth of the market are increasing incidence of neurological disorders such as epilepsy, migraine, and others, along with extensive technological advancements. For instance, in 2019, in India, as per the Neurology India’s data, the common neurological disorders are stroke with 37.9%, followed by headache disorder with 17.5%, epilepsy with 11.3% and cerebral palsy with 5.7%. In addition, increasing geriatric population is also one of the main factors as they are more susceptible to neurological disorders such as Parkinson’s disease, Alzheimer’s diseases and others.  Furthermore, the ongoing research and development activities to use neurostimulators for treating various conditions such as asthma, obsessive-compulsive disorders, and interstitial cystitis are anticipated to strengthen the growth of the market in upcoming years. According to the World Health Organization (WHO), 7.5% of Indians live with depression.

The Asia Pacific neurostimulation devices market is segmented into device type, application, company, and country. Based on device type, the market is categorized into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Out of which, the spinal cord stimulators segment dominated the market in 2022 and is expected to maintain its dominance during the forecast period. This is attributed to high growth in number of product approvals, and rising demand for treating neuropathic pain and spinal injuries. Based on country, China is expected to dominate the market during the forecast period. This is due to surge in research and development activity, and use of integrated internal neurostimulation device in proteomic, genomic and clinical diagnostics, coupled with the growing demand for advanced neurostimulation devices in the treatment of chronic pain management.

Major players operating in the Asia Pacific neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc. and others. The key market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements in order to expand their geographic reach and to increase their customer bases.


Download Free Sample Report

Objective of the Study:

  • To analyze and estimate the market size of Asia Pacific neurostimulation devices market from 2018 to 2021.
  • To estimate and forecast the market size of Asia Pacific neurostimulation devices market from 2022 to 2028 and growth rate until 2028.
  • To classify and forecast Asia Pacific neurostimulation devices market based on device type, application, company and country-wise distribution.
  • To identify dominant region or segment in the Asia Pacific neurostimulation devices market.
  • To identify drivers and challenges for Asia Pacific neurostimulation devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Asia Pacific neurostimulation devices market.
  • To conduct pricing analysis for Asia Pacific neurostimulation devices market.
  • To identify and analyze the profile of leading players operating in Asia Pacific neurostimulation devices market.
  • To identify key sustainable strategies adopted by market players in Asia Pacific neurostimulation devices market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the region. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers and presence of all major players across the region.

TechSci Research calculated the market size of Asia Pacific neurostimulation devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Neurostimulation devices manufacturers, suppliers and other stakeholders.
  • Government bodies such as regulating authorities and policy makers.
  • Organizations, forums and alliances related to neurostimulation devices.
  • Market research and consulting firms.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, Volume forecast, Company share, Competitive landscape, Growth factors, and Trends

Segments covered

Device Type

Application

Country

Country scope

China, India, Japan, South Korea, Singapore, Australia, Malaysia, Thailand, Vietnam, Indonesia

Key companies profiled

Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 Report Scope:

In this report, Asia Pacific neurostimulation devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Asia Pacific Neurostimulation Devices Market, By Device Type:
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Others
  • Asia Pacific Neurostimulation Devices Market, By Application:
    • Pain Management
    • Hearing Loss
    • Urinary Incontinence
    • Parkinson's Disease
    • Epilepsy
    • Others
  • Asia Pacific Neurostimulation Devices Market, By Country:
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Vietnam
    • Thailand
    • Indonesia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Asia Pacific neurostimulation devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Asia Pacific neurostimulation devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Asia Pacific Neurostimulation Devices Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.1.2.     By Volume (By Device Type)

5.2.  Market Share & Forecast

5.2.1.     By Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others)

5.2.2.     By Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others)

5.2.3.     By Company (2022)

5.2.4.     By Country

5.3.  Market Map

5.3.1.     By Device Type

5.3.2.     By Application

5.3.3.     By Country

5.4.  Asia Pacific: Country Analysis

5.4.1.     India Neurostimulation Devices Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.1.2.             By Volume (By Device Type)

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Device Type

5.4.1.2.2.             By Application

5.4.2.     China Neurostimulation Devices Market Outlook

5.4.2.1.         Market Size & Forecast

5.4.2.1.1.             By Value

5.4.2.1.2.             By Volume (By Device Type)

5.4.2.2.         Market Share & Forecast

5.4.2.2.1.             By Device Type

5.4.2.2.2.             By Application

5.4.3.     Japan Neurostimulation Devices Market Outlook

5.4.3.1.         Market Size & Forecast

5.4.3.1.1.             By Value

5.4.3.1.2.             By Volume (By Device Type)

5.4.3.2.         Market Share & Forecast

5.4.3.2.1.             By Device Type

5.4.3.2.2.             By Application

5.4.4.     South Korea Neurostimulation Devices Market Outlook

5.4.4.1.         Market Size & Forecast

5.4.4.1.1.             By Value

5.4.4.1.2.             By Volume (By Device Type)

5.4.4.2.         Market Share & Forecast

5.4.4.2.1.             By Device Type

5.4.4.2.2.             By Application

5.4.5.     Australia Neurostimulation Devices Market Outlook

5.4.5.1.         Market Size & Forecast

5.4.5.1.1.             By Value

5.4.5.1.2.             By Volume (By Device Type)

5.4.5.2.         Market Share & Forecast

5.4.5.2.1.             By Device Type

5.4.5.2.2.             By Application

5.4.6.     Singapore Neurostimulation Devices Market Outlook

5.4.6.1.         Market Size & Forecast

5.4.6.1.1.             By Value

5.4.6.1.2.             By Volume (By Device Type)

5.4.6.2.         Market Share & Forecast

5.4.6.2.1.             By Device Type

5.4.6.2.2.             By Application

5.4.7.     Malaysia Neurostimulation Devices Market Outlook

5.4.7.1.         Market Size & Forecast

5.4.7.1.1.             By Value

5.4.7.1.2.             By Volume (By Device Type)

5.4.7.2.         Market Share & Forecast

5.4.7.2.1.             By Device Type

5.4.7.2.2.             By Application

5.4.8.     Vietnam Neurostimulation Devices Market Outlook

5.4.8.1.         Market Size & Forecast

5.4.8.1.1.             By Value

5.4.8.1.2.             By Volume (By Device Type)

5.4.8.2.         Market Share & Forecast

5.4.8.2.1.             By Device Type

5.4.8.2.2.             By Application

5.4.9.     Thailand Neurostimulation Devices Market Outlook

5.4.9.1.         Market Size & Forecast

5.4.9.1.1.             By Value

5.4.9.1.2.             By Volume (By Device Type)

5.4.9.2.         Market Share & Forecast

5.4.9.2.1.             By Device Type

5.4.9.2.2.             By Application

5.4.10.  Indonesia Neurostimulation Devices Market Outlook

5.4.10.1.      Market Size & Forecast

5.4.10.1.1.           By Value

5.4.10.1.2.           By Volume (By Device Type)

5.4.10.2.      Market Share & Forecast

5.4.10.2.1.           By Device Type

5.4.10.2.2.           By Application

6.    Market Dynamics

6.1.  Drivers

6.2.  Challenges

7.    Market Trends & Developments

7.1.  Mergers & Acquisitions

7.2.  Product Launches

7.3.  Technological Advancements

8.    Competitive Landscape

8.1.  Competition Outlook

8.2.  Company Profiles

8.2.1.     Abbott Laboratories, Inc

8.2.2.     Aleva Neurotherapeutics SA

8.2.3.     Boston Scientific Corporation

8.2.4.     ElectroCore Inc.

8.2.5.     EndoStim Inc.

8.2.6.     Medtronic Plc

8.2.7.     Nevro Corporation

8.2.8.     Neuronetics Inc

8.2.9.     NeuroSigma, Inc.

8.2.10.  Synapse Biomedical Inc

9.    Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Rising prevalence of neurological disorders, and technological advancements are expected to drive Asia Pacific neurostimulation devices market during forecast period.

down-arrow

Asia Pacific neurostimulation devices market is segmented into device type, application, company, and country.

down-arrow

Based on device type segment, spinal cord stimulator segment is expected to anticipate the growth of the Asia Pacific neurostimulation devices market during forecast period. This is due to the high market penetration of commercially available products, and growing adoption of advanced technology.

down-arrow

Major companies operating in Asia Pacific neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Asia Pacific Neurostimulation Devices Market to Register High Growth During Forecast Period

Jul, 2020

Rising prevalence of chronic diseases is expected to drive the growth of Asia Pacific neurostimulation devices market

Why Choose Us